13-cis-retinoic acid,Isotretinoin

13-cis-retinoic acid,isotretinoin is a lipid of Prenol Lipids (PR) class. 13-cis-retinoic acid,isotretinoin is associated with abnormalities such as Dermatitis, Phototoxic. The involved functions are known as Regulation, Pigment, chromophore, Light absorption and Pupil constriction. 13-cis-retinoic acid,isotretinoin often locates in Neurosecretory Systems. The associated genes with 13-cis-retinoic acid,Isotretinoin are melanopsin.

Cross Reference

Introduction

To understand associated biological information of 13-cis-retinoic acid,Isotretinoin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 13-cis-retinoic acid,Isotretinoin?

13-cis-retinoic acid,Isotretinoin is suspected in Dermatitis, Phototoxic and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 13-cis-retinoic acid,Isotretinoin

MeSH term MeSH ID Detail
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Acne Vulgaris D000152 35 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Lung Neoplasms D008175 171 associated lipids
Total 4

PubChem Associated disorders and diseases

What pathways are associated with 13-cis-retinoic acid,Isotretinoin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 13-cis-retinoic acid,Isotretinoin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 13-cis-retinoic acid,Isotretinoin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 13-cis-retinoic acid,Isotretinoin?

There are no associated biomedical information in the current reference collection.

What genes are associated with 13-cis-retinoic acid,Isotretinoin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 13-cis-retinoic acid,Isotretinoin?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 13-cis-retinoic acid,Isotretinoin

Download all related citations
Per page 10 20 50 100 | Total 2952
Authors Title Published Journal PubMed Link
Cakmakci A et al. Polycythemia in a patient treated with isotretinoin. 2001 Jul-Aug Ann Pharmacother pmid:11485156
Laroche ML et al. Cerebral ischemia probably related to isotretinoin. 2007 Ann Pharmacother pmid:17472998
Marroni M et al. Isotretinoin: possible cause of acute seizure and confusion. 1993 Ann Pharmacother pmid:8329809
Moeller KE and Touma SC Prolonged thrombocytopenia associated with isotretinoin. 2003 Ann Pharmacother pmid:14565796
Enders SJ and Enders JM Isotretinoin and psychiatric illness in adolescents and young adults. 2003 Jul-Aug Ann Pharmacother pmid:12841827
Reniers DE and Howard JM Isotretinoin-induced inflammatory bowel disease in an adolescent. 2001 Ann Pharmacother pmid:11675849
Cruz NI and Korchin L Inhibition of human keloid fibroblast growth by isotretinoin and triamcinolone acetonide in vitro. 1994 Ann Plast Surg pmid:7810956
Yeo PM et al. Paradoxical Worsening of Truncal Acne with Doxycycline. 2016 Ann. Acad. Med. Singap. pmid:27748793
Börner AR et al. Isotretinoin in metastatic thyroid cancer. 1997 Ann. Intern. Med. pmid:9245241
Osborne C et al. Isotretinoin in respiratory papillomatosis. 2000 Ann. Intern. Med. pmid:10858163
Roach M A malignant eccrine poroma responds to isotretinoin (13-cis-retinoic acid). 1983 Ann. Intern. Med. pmid:6312862
Rodondi N et al. High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: a pharmacogenetic study. 2002 Ann. Intern. Med. pmid:11955026
Summary for patients. An unusual "side effect" of an acne drug. 2002 Ann. Intern. Med. pmid:11955046
Friedland M et al. Malignant eccrine poroma and isotretinoin. 1984 Ann. Intern. Med. pmid:6322633
Flynn WJ et al. Pancreatitis associated with isotretinoin-induced hypertriglyceridemia. 1987 Ann. Intern. Med. pmid:3035979
Lippman SM and Meyskens FL Treatment of advanced squamous cell carcinoma of the skin with isotretinoin. 1987 Ann. Intern. Med. pmid:3477106
Sakai Y et al. 13-cis Retinoic acid (accutane) suppresses hippocampal cell survival in mice. 2004 Ann. N. Y. Acad. Sci. pmid:15251924
Mestre JR et al. Phorbol ester-mediated induction of cyclooxygenase-2 gene expression is inhibited by retinoids. 1997 Ann. N. Y. Acad. Sci. pmid:9616751
Kooistra T et al. Enhancement of tissue-type plasminogen activator levels by retinoids in rat tissues in vivo. 1992 Ann. N. Y. Acad. Sci. pmid:1309036
Lippman SM and Hong WK 13-cis-retinoic acid plus interferon-alpha in solid tumors: keeping the cart behind the horse. 1994 Ann. Oncol. pmid:8075044
Toma S et al. Efficacy of recombinant alpha-interferon 2a and 13-cis-retinoic acid in the treatment of squamous cell carcinoma. 1994 Ann. Oncol. pmid:8075053
Cascinu S et al. Phase II trial of 13-cis retinoic acid plus interferon-alpha in advanced squamous cell carcinoma of head and neck, refractory to chemotherapy. 1996 Ann. Oncol. pmid:8839916
Dimery IW et al. Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity. 1997 Ann. Oncol. pmid:9093712
Goodwin WJ et al. Inhibition of hamster tongue carcinogenesis by selenium and retinoic acid. 1986 Mar-Apr Ann. Otol. Rhinol. Laryngol. pmid:3083753
Ohta A et al. Retinoid modulation of collagenase production by adherent human mononuclear cells in culture. 1987 Ann. Rheum. Dis. pmid:3036026
Rice D et al. The risk of second primary tumors after resection of stage I nonsmall cell lung cancer. 2003 Ann. Thorac. Surg. pmid:14529975
Kudelka AP et al. Metastatic adenocarcinoma of the endometrium treated with 13-cis-retinoic acid plus interferon-alpha. 1993 Anticancer Drugs pmid:8358060
Recchia F et al. Multicenter phase II study of chemoimmunotherapy in the treatment of metastatic melanoma. 2008 Anticancer Drugs pmid:18176117
Rinaldi DA et al. Phase II study of 13-cis-retinoic acid and interferon-alpha 2a in patients with advanced squamous cell lung cancer. 1993 Anticancer Drugs pmid:8457712
Ruotsalainen T et al. Interferon-alpha and 13-cis-retinoic acid as maintenance therapy after high-dose combination chemotherapy with growth factor support for small cell lung cancer--a feasibility study. 2000 Anticancer Drugs pmid:10789592
Gravis G et al. Phase II study of a combination of low-dose cisplatin with 13-cis-retinoic acid and interferon-alpha in patients with advanced head and neck squamous cell carcinoma. 1999 Anticancer Drugs pmid:10378671
Piamsomboon S et al. Prolonged stabilization of progressive squamous cell cancer of the cervix with interferon-alpha and 13-cis-retinoic acid: report of two cases and review of the literature. 1996 Anticancer Drugs pmid:8949994
Cabrespine A et al. In vitro assessment of cytotoxic agent combinations for hormone-refractory prostate cancer treatment. 2005 Anticancer Drugs pmid:15746578
Johanning GL et al. Effect of high retinoid doses on RAR-beta mRNA expression in female B6D2F1 mice. 2001 May-Jun Anticancer Res. pmid:11497248
Somos S and Farkas B Immunomodulatory treatment with low-dose interferon-alpha and oral retinoic acid in lymphangioma-like Kaposi's sarcoma. 2000 Jan-Feb Anticancer Res. pmid:10769722
Recchia F et al. Immunotherapy in patients with less than complete response to chemotherapy. 2009 Anticancer Res. pmid:19331204
Recchia F et al. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study. 2000 May-Jun Anticancer Res. pmid:10928138
Somos S et al. Cancer protection in xeroderma pigmentosum variant (XP-V). 1999 May-Jun Anticancer Res. pmid:10472330
Toma S et al. Efficacy of the association of 13-cis-retinoic acid (13cRA) and alpha-interferon 2a (alpha-IFN 2a) in moderate-severe cervical intraepithelial neoplasia (CIN II-III): a pilot study. 1996 Mar-Apr Anticancer Res. pmid:8687154
Recchia F et al. Phase II randomized study of interleukin-2 with or without 13-cis retinoic acid as maintenance therapy in patients with advanced cancer responsive to chemotherapy. 2005 Jul-Aug Anticancer Res. pmid:16080579
Kröger MJ et al. Life quality of patients with metastatic renal cell carcinoma and chemo-immunotherapy--a pilot study. 1999 Mar-Apr Anticancer Res. pmid:10365144
Isaacs CE et al. Inhibition of herpes simplex virus replication by retinoic acid. 1997 Antiviral Res. pmid:9021053
Pachajoa H and Ordoñez A [Isotretinoin embryopathy with microtia-anotia and congenital heart disease: case report]. 2012 May-Jun Arch Argent Pediatr pmid:22760759
Eimer L et al. [Darier-White disease treated with oral isotretinoin]. 2011 Arch Argent Pediatr pmid:21829859
DiGiovanna JJ et al. Osteoporosis is a toxic effect of long-term etretinate therapy. 1995 Arch Dermatol pmid:7503569
Weiss J et al. Bilateral corneal opacities. Occurrence in a patient treated with oral isotretinoin. 1981 Arch Dermatol pmid:6938168
Katz RA Isotretinoin treatment of recalcitrant warts in an immunosuppressed man. 1986 Arch Dermatol pmid:3455807
McElwee NE et al. An observational study of isotretinoin recipients treated for acne in a health maintenance organization. 1991 Arch Dermatol pmid:1825596
Leachman SA et al. Bone densities in patients receiving isotretinoin for cystic acne. 1999 Arch Dermatol pmid:10456346
Newton RC et al. Mechanism-oriented assessment of isotretinoin in chronic or subacute cutaneous lupus erythematosus. 1986 Arch Dermatol pmid:3511858